Cefpodoxime Proxetil Tablets

Get a Price/Quote

Cefpodoxime Proxetil Tablets Specification

Therapeutic Class
Third Generation Cephalosporin Antibiotic

Route of Administration
Oral

Packaging Size
10 x 10 Tablets

Regulatory Approval
WHO-GMP Certified

Available Strengths
100 mg, 200 mg

Storage Conditions
Store in a cool, dry place below 25°C, away from light and moisture

Shelf Life
24 months

Packaging Type
Strip

Composition
Cefpodoxime Proxetil

Usage/Application
Clinical, Hospital, Personal

Side Effects
Nausea, Diarrhea, Abdominal pain, Rash, Allergic reactions

Prescription/Non prescription
Prescription

Indications
Bacterial infections, Respiratory tract infections, Urinary tract infections, Skin and soft tissue infections, Pharyngitis, Tonsillitis, Gonorrhea

Strength
100 mg / 200 mg (as per market specification)

Dosage Form
Tablets

Cefpodoxime Proxetil Tablets Trade Information

Supply Ability
100 Per Day

Delivery Time
7 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

About Cefpodoxime Proxetil Tablets

Experience the dominant efficacy of Cefpodoxime Proxetil Tablets, carefully crafted by Torrent under the first-string brand UVACEF. These third-generation cephalosporin antibiotics are ideal for clinical, hospital, and personal use, targeting lofty standards in bacterial infection management. Available in customizable strengths of 100 mg and 200 mg, each strip contains 10 tablets. With WHO-GMP certification, a solid 24-month shelf life, and reliable export capabilities from India, Add to Cart now or Try Now for trusted therapeutic results. Prescription-only, packed securely to preserve potency.

Versatile Application & Defining Features

Cefpodoxime Proxetil Tablets are deployed in hospitals, clinics, and personal healthcare settings for the treatment of respiratory tract, urinary tract, skin and soft tissue infections, pharyngitis, tonsillitis, and gonorrhea. The oral route ensures ease of administration while their lofty bacterial coverage stands out. Each tablet is engineered for optimal stability, stored below 25C and shielded from moisture and sunlight, ensuring reliable outcomes on prescribed surfaces and patient profiles.

Supply Capacity & Export Excellence

With a premium supply ability, Cefpodoxime Proxetil Tablets are sourced directly from manufacturer Torrent in India. The main export markets include leading regions worldwide, prized for their WHO-GMP certification. Samples are available upon request, offering clarity on product efficacy prior to an outlay or final asking price. Exporters, importers, manufacturers, and suppliers benefit from efficient and regulated global distribution, making these tablets a top-tier choice for international antibiotic needs.

Strength	200mg
Form	Tablet
Manufacturer	Torrent
Brand Name	UVACEF
Composition	Cefpodoxime Proxetil Tablets IP
Shell Life	24 months
Packaging Size	10 tablets
Country of Origin	Made in India

FAQ's of Cefpodoxime Proxetil Tablets:

Q: How should Cefpodoxime Proxetil Tablets be administered?

A: Cefpodoxime Proxetil Tablets are taken orally as directed by a physician. They are available in strengths of 100 mg and 200 mg to match individual therapeutic requirements.

Q: What health conditions are treated with Cefpodoxime Proxetil Tablets?

A: These tablets address bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, pharyngitis, tonsillitis, and gonorrhea.

Q: When should stored Cefpodoxime Proxetil Tablets be discarded?

A: The tablets should be used within their 24-month shelf life. Any tablets remaining after this period should be safely discarded as their efficacy may decline.

Q: Where are Cefpodoxime Proxetil Tablets manufactured and exported from?

A: Manufactured by Torrent and branded as UVACEF, these tablets originate in India and are supplied globally, adhering to WHO-GMP certification standards.

Q: What makes Cefpodoxime Proxetil Tablets a premium choice for hospitals and clinics?

A: Their third-generation cephalosporin composition, customizable strengths, stable formulation, and international regulatory approval make them a dominant, first-string solution for bacterial infections.